Form 4: Eli Lilly Director Acquires Shares Through Deferral Plan

Director Juan R. Luciano acquired 19 shares of Eli Lilly common stock through a deferral plan, as reported in a recent SEC filing.

Summary

• Director Juan R. Luciano acquired 19 shares of Eli Lilly & Co. common stock on May 20, 2024.
• The shares were acquired at a price of $783.18 per share.
• The acquisition was made through the Lilly Directors' Deferral Plan, where the shares are deferred in lieu of cash compensation.
• The shares will be settled in common stock following Mr. Luciano's separation from service.
• Following the transaction, Mr. Luciano directly owns 15,697 shares of Eli Lilly common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects a director increasing their stake in the company, which is generally seen as a sign of confidence. However, it is a routine transaction.

Positives

• The acquisition of shares by a director can be seen as a positive sign of confidence in the company's future.
• The use of a deferral plan aligns the director's interests with the long-term performance of the company.

Future Outlook

The acquired shares will be settled in common stock following the reporting person's separation from service.

Industry Context

This is a routine transaction for a director of a public company, and it is common for directors to receive stock as part of their compensation.

Comparison to Industry Standards

• Director share acquisitions are a common practice across publicly traded companies, often as part of compensation packages.
• Deferral plans are also a standard method for aligning director interests with long-term company performance, similar to practices at companies like Pfizer (PFE) and Johnson & Johnson (JNJ).

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it indicates a director's confidence in the company.

Key Dates

Keywords

Eli Lilly, Director, Share Acquisition, Deferral Plan, Stock Ownership, SEC Form 4, LLY